Taiwan Cell Manufacturing Company Ltd.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
We specialize in providing high-quality viral vectors (especially lentiviral vectors, LVVs) and cell therapy products, which can be tailored to your specific needs. LVVs play a critical role in the genetic modification of T cells (such as Chimeric Antigen Receptor T cells / CAR-T). We offer advanced LVV manufacturing solutions that provide comprehensive support for the development of genetically modified T cells, from research and development (R&D) to full-scale commercialization.
Furthermore, our expertise also covers the manufacturing of non-genetically modified cells, such as dendritic cells (DCs), cytokine-induced killer cells (CIKs), natural killer cells (NKs), and stem cells. We deeply understand the complexity of regulatory compliance; therefore, each of our CDMO services is equipped with comprehensive regulatory support to assist you in perfecting your CMC (Chemistry, Manufacturing, and Controls) documentation.
From pioneering research to life-changing therapies, Taiwan Cell Manufacturing Company Ltd. is your reliable partner in developing next-generation treatments. Let us work together to advance the future of medicine.
Furthermore, our expertise also covers the manufacturing of non-genetically modified cells, such as dendritic cells (DCs), cytokine-induced killer cells (CIKs), natural killer cells (NKs), and stem cells. We deeply understand the complexity of regulatory compliance; therefore, each of our CDMO services is equipped with comprehensive regulatory support to assist you in perfecting your CMC (Chemistry, Manufacturing, and Controls) documentation.
From pioneering research to life-changing therapies, Taiwan Cell Manufacturing Company Ltd. is your reliable partner in developing next-generation treatments. Let us work together to advance the future of medicine.
The content above was translated by Ai
Founded Year
2021
Unified Business No.
91062335
Status
Active
Number of Employees
0
Total Paid-in
Capital
505,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
tcmc is a biotechnology company focusing on the field of cell and gene therapy, providing comprehensive contract development and manufacturing organization (CDMO) services. We can support the CMC development required for IND applications, as well as comprehensive solutions for the clinical trial and commercial manufacturing stages.
Leveraging our professional capabilities in large-scale process development, GMP manufacturing, and viral vector technology (vectorology) development, tcmc has built a robust and diverse manufacturing platform capable of supporting the development and production of various cell and gene therapy products. Based on the support of policies and regulations, we are committed to helping clients accelerate product development timelines while effectively reducing manufacturing costs.
Leveraging our professional capabilities in large-scale process development, GMP manufacturing, and viral vector technology (vectorology) development, tcmc has built a robust and diverse manufacturing platform capable of supporting the development and production of various cell and gene therapy products. Based on the support of policies and regulations, we are committed to helping clients accelerate product development timelines while effectively reducing manufacturing costs.
The content above was translated by Ai
